Does USTEKINUMAB Cause Haemorrhage? 229 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 229 reports of Haemorrhage have been filed in association with USTEKINUMAB (PYZCHIVA). This represents 0.3% of all adverse event reports for USTEKINUMAB.
229
Reports of Haemorrhage with USTEKINUMAB
0.3%
of all USTEKINUMAB reports
7
Deaths
48
Hospitalizations
How Dangerous Is Haemorrhage From USTEKINUMAB?
Of the 229 reports, 7 (3.1%) resulted in death, 48 (21.0%) required hospitalization, and 17 (7.4%) were considered life-threatening.
Is Haemorrhage Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for USTEKINUMAB. However, 229 reports have been filed with the FAERS database.
What Other Side Effects Does USTEKINUMAB Cause?
Drug ineffective (12,471)
Off label use (10,990)
Product dose omission issue (9,405)
Fatigue (5,457)
Product use issue (5,008)
Psoriasis (4,955)
Pain (4,872)
Rash (4,736)
Crohn's disease (4,662)
Arthralgia (4,608)
What Other Drugs Cause Haemorrhage?
RIVAROXABAN (6,571)
APIXABAN (4,770)
EMICIZUMAB-KXWH (3,612)
WARFARIN (2,930)
ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT (2,925)
ASPIRIN (2,878)
ADALIMUMAB (2,681)
IBRUTINIB (1,907)
CLOPIDOGREL BISULFATE (1,762)
INSULIN LISPRO (1,614)
Which USTEKINUMAB Alternatives Have Lower Haemorrhage Risk?
USTEKINUMAB vs USTEKINUMAB-STBA
USTEKINUMAB vs VADADUSTAT
USTEKINUMAB vs VALACYCLOVIR
USTEKINUMAB vs VALBENAZINE
USTEKINUMAB vs VALBENAZINE DITOSYLATE